NCT05920226Active, not recruiting
Myocardial Fibrosis in Patients With Permanent Pacemakers
Source: ClinicalTrials.gov · Last updated 11 Apr 2024
Brief summary (registry, in English)
Patients with cardiac pathology and arrhythmias including those who have indications for pacemakers implantation will be included in the study. We will determine the influence of pacemaker implantation with the localization of the ventricular electrode in the top of the right ventricle or the middle third of the right ventricle according to echocardiographic and electrocardiographic parameters, congestive heart failure progression, patients' quality of life and follow-up therapy of patients with identified myocardial fibrosis with existing pacemaker. Study of changes in echocardiography, electrocardiography, myocardial fibrosis markers, the quality of life of patients will allow to choose the most optimal localization of the ventricular electrode during implantation of the permanent pacemakers system in order to improve the quality of life of the patients.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 300 (estimated)
- First submitted
- 13 Jun 2023
- Start date
- 1 Jul 2023
- Primary completion date
- 1 Jul 2027
- Lead sponsor
- Ryazan State Medical University
- Diseases
- Atrial fibrillation
- NCT number
- NCT05920226
What you commit to
- Study type: Observational
- Planned participants: 300
- From 1 Jul 2023 to the primary completion date, 1 Jul 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- . active cancer or remission period less than 5 years;
- . active viral hepatitis, HIV or syphilis;
Age
- . men or women younger than 60 years of age or older than 85 years of age;
Other
- . decompensated somatic pathology;
- . withdrawn consent.
Who the study is looking for
- men or women over 60 years of age
- . signed informed consent form
- . presence of cardiac pathology and arrhythmia requiring pacemakers implantation (group A).
- . presence of cardiac pathology and arrhythmia not requiring pacemaker implantation (group B).
Age in the registry: 60 years to 85 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ryazan State Medical University Coordinator of this site? Confirm its status | Ryazan | Russia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.